About Pecsi Tudomanyegyetem, Klinikai Kozpont,
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
10
Pfizer
10
Janssen Research & Development, LLC
6
Amgen
4
Actelion
3
Bristol-Myers Squibb
2
Eli Lilly and Company
2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
2
ADC Therapeutics S.A.
1
AVEO Pharmaceuticals, Inc.
1
Astex Pharmaceuticals, Inc.
1
Clinical Trials at Pecsi Tudomanyegyetem, Klinikai Kozpont,
During the past decade, Pecsi Tudomanyegyetem, Klinikai Kozpont, conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 26 clinical trials were completed, i.e. on
average, 61.9% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 18 clinical trials were completed. i.e. 120%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke
2009-12-01
2012-04-01
Terminated
446
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
2009-12-01
2014-10-01
Completed
1,156
A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years
2011-09-27
2016-08-10
Completed
295
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
2012-07-20
2016-05-27
Completed
593
A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures
2012-02-21
2019-08-22
Completed
605
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
2012-04-01
2015-05-01
Completed
614
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
2012-10-01
2020-08-06
Completed
944
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Pecsi Tudomanyegyetem, Klinikai Kozpont," #1 sponsor was "Bayer" with 10 trials, followed by "Pfizer" with 10 trials
sponsored, "Janssen Research & Development, LLC" with 6 trials sponsored, "Amgen" with 4 trials sponsored and "Actelion"
with 4 trials sponsored. Other sponsors include 14 different institutions and
companies that sponsored additional 21 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Pecsi Tudomanyegyetem, Klinikai Kozpont,"
#1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were
collaborators in the rest 17 trials.
Clinical Trials Conditions at Pecsi Tudomanyegyetem, Klinikai Kozpont,
According to Clinical.Site data, the most researched conditions in "Pecsi Tudomanyegyetem, Klinikai Kozpont," are
"Ulcerative Colitis" (3 trials), "Acute Myeloid Leukemia" (2 trials), "Depressive Disorder, Major" (2 trials), "Epilepsy, Partial Seizures" (2 trials) and "Psoriasis" (2 trials). Many other conditions were trialed in "Pecsi Tudomanyegyetem, Klinikai Kozpont," in a lesser frequency.
Clinical Trials Intervention Types at Pecsi Tudomanyegyetem, Klinikai Kozpont,
Most popular intervention types in "Pecsi Tudomanyegyetem, Klinikai Kozpont," are "Drug" (50 trials), "Other" (9 trials), "Biological" (2 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (24 trials), "Apixaban" (2 trials), "Apixaban matching placebo" (2 trials), "BAY2433334" (2 trials) and "BAY2433334 matching placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Pecsi Tudomanyegyetem, Klinikai Kozpont,
The vast majority of trials in "Pecsi Tudomanyegyetem, Klinikai Kozpont," are
50 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Pecsi Tudomanyegyetem, Klinikai Kozpont,
Currently, there are NaN active trials in "Pecsi Tudomanyegyetem, Klinikai Kozpont,".
undefined are not yet recruiting,
12 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 23 completed trials in Pecsi Tudomanyegyetem, Klinikai Kozpont,,
undefined suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Pecsi Tudomanyegyetem, Klinikai Kozpont,, 0 "Phase 1"
clinical trials were conducted, 14 "Phase 2" clinical
trials and 39 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".